AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 76-100/156
HUMAN RECOMBINANT INTERFERON-INDUCIBLE PROTEIN-10 INHIBITS PROLIFERATION OF IMMATURE NORMAL AND ACUTE MYELOGENOUS LEUKEMIA PROGENITORS
Authors: SARRIS AH TALPAZ M DEISSEROTH AB ESTROV Z
Citation: Ah. Sarris et al., HUMAN RECOMBINANT INTERFERON-INDUCIBLE PROTEIN-10 INHIBITS PROLIFERATION OF IMMATURE NORMAL AND ACUTE MYELOGENOUS LEUKEMIA PROGENITORS, Blood, 86(10), 1995, pp. 2074-2074
BCL-X LONG ISOFORM PROTECTS CELLS FROM APOPTOTIC CELL-DEATH EXPRESSEDIN POOR-PROGNOSIS SUBSETS OF AML, WHILE BCL-X SHORT, WHICH PROMOTES CELL-DEATH, IS EXPRESSED IN GOOD PROGNOSIS SUBSETS OF ACUTE MYELOGENOUSLEUKEMIA (AML)
Authors: DENG G DEISSEROTH AB
Citation: G. Deng et Ab. Deisseroth, BCL-X LONG ISOFORM PROTECTS CELLS FROM APOPTOTIC CELL-DEATH EXPRESSEDIN POOR-PROGNOSIS SUBSETS OF AML, WHILE BCL-X SHORT, WHICH PROMOTES CELL-DEATH, IS EXPRESSED IN GOOD PROGNOSIS SUBSETS OF ACUTE MYELOGENOUSLEUKEMIA (AML), Blood, 86(10), 1995, pp. 2342-2342
LOW AND MAXIMALLY PHOSPHORYLATED LEVELS OF THE RETINOBLASTOMA (RB) PROTEIN CONFER POOR-PROGNOSIS AT DIAGNOSIS IN NEWLY-DIAGNOSED ACUTE MYELOGENOUS LEUKEMIA - A PROSPECTIVE-STUDY
Authors: KOMBLAU SM XU HJ HU SX ESTEY E BENEDICT W DEISSEROTH AB
Citation: Sm. Komblau et al., LOW AND MAXIMALLY PHOSPHORYLATED LEVELS OF THE RETINOBLASTOMA (RB) PROTEIN CONFER POOR-PROGNOSIS AT DIAGNOSIS IN NEWLY-DIAGNOSED ACUTE MYELOGENOUS LEUKEMIA - A PROSPECTIVE-STUDY, Blood, 86(10), 1995, pp. 2384-2384
TACROLIMUS AND MINI-METHOTREXATE VS T-CELL DEPLETION, CYCLOSPORINE AND IMMUNOTOXIN FOR PREVENTION OF ACUTE GRAFT-VS-HOST DISEASE (OVHD) AFTER HLA-NONIDENTICAL MARROW TRANSPLANTATION
Authors: PRZEPIORKA D IPPOLITI C KHOURI I STEIN L VANBESIEN K MEHRA R GIRALT S GAJEWSKI J FRITSCHE H DEISSEROTH AB CLEARY K ANDERSSON B CHAMPLIN R
Citation: D. Przepiorka et al., TACROLIMUS AND MINI-METHOTREXATE VS T-CELL DEPLETION, CYCLOSPORINE AND IMMUNOTOXIN FOR PREVENTION OF ACUTE GRAFT-VS-HOST DISEASE (OVHD) AFTER HLA-NONIDENTICAL MARROW TRANSPLANTATION, Blood, 86(10), 1995, pp. 2471-2471
ALTERED PATTERNS OF ACTIVATION OF JAK KINASES BY INTERFERONS IN CHRONIC MYELOGENOUS LEUKEMIA (CML) CELLS
Authors: HENDERSON Y DEISSEROTH AB
Citation: Y. Henderson et Ab. Deisseroth, ALTERED PATTERNS OF ACTIVATION OF JAK KINASES BY INTERFERONS IN CHRONIC MYELOGENOUS LEUKEMIA (CML) CELLS, Blood, 86(10), 1995, pp. 2654-2654
DIFFERENTIAL DISPLAY POLYMERASE CHAIN-REACTION (PCR) SHOWS INCREASED EXPRESSION OF CHAPERONIN PROTEINS IN BCR-ABL TRANSFECTED MOUSE MYELOIDCELLS
Authors: LANE C YUNG K GUO XY DEISSEROTH AB
Citation: C. Lane et al., DIFFERENTIAL DISPLAY POLYMERASE CHAIN-REACTION (PCR) SHOWS INCREASED EXPRESSION OF CHAPERONIN PROTEINS IN BCR-ABL TRANSFECTED MOUSE MYELOIDCELLS, Blood, 86(10), 1995, pp. 2919-2919
SINGLE TUBE NESTED PCR FOR DETECTION OF THE INVERSION-16 ABNORMALITY IN ACUTE MYELOGENOUS LEUKEMIA (AML)
Authors: CLAXTON DF XIE QS ESTEY E DEISSEROTH AB
Citation: Df. Claxton et al., SINGLE TUBE NESTED PCR FOR DETECTION OF THE INVERSION-16 ABNORMALITY IN ACUTE MYELOGENOUS LEUKEMIA (AML), Blood, 86(10), 1995, pp. 3001-3001
ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION FOR REFRACTORY LEUKEMIA AND LYMPHOMA - POTENTIAL ADVANTAGE OF BLOOD OVER MARROW ALLOGRAFTS
Authors: KORBLING M PRZEPIORKA D HUH YO ENGEL H VANBESIEN K GIRALT S ANDERSSON B KLEINE HD SEONG D DEISSEROTH AB ANDREEFF M CHAMPLIN R
Citation: M. Korbling et al., ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION FOR REFRACTORY LEUKEMIA AND LYMPHOMA - POTENTIAL ADVANTAGE OF BLOOD OVER MARROW ALLOGRAFTS, Blood, 85(6), 1995, pp. 1659-1665
DETECTION OF RESIDUAL LEUKEMIC-CELLS IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA BY THE FLUORESCENCE IN-SITU HYBRIDIZATION METHOD - POTENTIAL FOR PREDICTING RELAPSE
Authors: ZHAO L CHANG KS ESTEY EH HAYES K DEISSEROTH AB LIANG JC
Citation: L. Zhao et al., DETECTION OF RESIDUAL LEUKEMIC-CELLS IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA BY THE FLUORESCENCE IN-SITU HYBRIDIZATION METHOD - POTENTIAL FOR PREDICTING RELAPSE, Blood, 85(2), 1995, pp. 495-499
PERCENTAGE OF PHILADELPHIA-CHROMOSOME (PH)-NEGATIVE AND PH-POSITIVE CELLS FOUND AFTER AUTOLOGOUS TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA DEPENDS ON PERCENTAGE OF DIPLOID-CELLS INDUCED BY CONVENTIONAL-DOSE CHEMOTHERAPY BEFORE COLLECTION OF AUTOLOGOUS CELLS
Authors: TALPAZ M KANTARJIAN H LIANG J CALVERT L HAMER J TIBBITS P DURETT A CLAXTON D GIRALT S KHOURI I PRZEPIORKA D VANBESIEN K ANDERSSON B MEHRA R GAJEWSKI J SEONG D HESTER J ESTEY E KORBLING M POLLICARDO N BERENSON R HEIMFELD S CHAMPLIN R DEISSEROTH AB
Citation: M. Talpaz et al., PERCENTAGE OF PHILADELPHIA-CHROMOSOME (PH)-NEGATIVE AND PH-POSITIVE CELLS FOUND AFTER AUTOLOGOUS TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA DEPENDS ON PERCENTAGE OF DIPLOID-CELLS INDUCED BY CONVENTIONAL-DOSE CHEMOTHERAPY BEFORE COLLECTION OF AUTOLOGOUS CELLS, Blood, 85(11), 1995, pp. 3257-3263
RECENT ADVANCES IN THE APPLICATION OF GENE-THERAPY TO HUMAN-DISEASE
Authors: HANANIA EG KAVANAGH J HORTOBAGYI G GILES RE CHAMPLIN R DEISSEROTH AB
Citation: Eg. Hanania et al., RECENT ADVANCES IN THE APPLICATION OF GENE-THERAPY TO HUMAN-DISEASE, The American journal of medicine, 99(5), 1995, pp. 537-552
WT1 AND GATA1 EXPRESSION PATTERNS IN HUMAN LEUKEMIA
Authors: PATMASIRIWAT P FRAIZER G KANTARJIAN H DEISSEROTH AB SAUNDERS GF
Citation: P. Patmasiriwat et al., WT1 AND GATA1 EXPRESSION PATTERNS IN HUMAN LEUKEMIA, American journal of human genetics, 57(4), 1995, pp. 398-398
DEVELOPMENT OF A SENSITIVE PCR TO DETECT ALLELE LOSS IN A MODEL HEMATOPOIETIC NEOPLASM
Authors: FAIRMAN J CLAXTON D WILLMAN CL DEISSEROTH AB NAGARAJAN L
Citation: J. Fairman et al., DEVELOPMENT OF A SENSITIVE PCR TO DETECT ALLELE LOSS IN A MODEL HEMATOPOIETIC NEOPLASM, PCR methods and applications, 4(1), 1994, pp. 6-12
THE DNA-BINDING AND TRANSCRIPTION-ACTIVATION ABILITIES OF P53 ARE NECESSARY BUT NOT SUFFICIENT FOR ITS ANTIPROLIFERATION FUNCTION
Authors: ZHANG W RANDHAWA GS GUO XY DEISSEROTH AB
Citation: W. Zhang et al., THE DNA-BINDING AND TRANSCRIPTION-ACTIVATION ABILITIES OF P53 ARE NECESSARY BUT NOT SUFFICIENT FOR ITS ANTIPROLIFERATION FUNCTION, Cell growth & differentiation, 5(7), 1994, pp. 705-710
CONFORMATIONAL CHANGE OF P53 PROTEIN IN GROWTH FACTOR-STIMULATED HUMAN MYELOGENOUS LEUKEMIA-CELLS
Authors: ZHANG W DEISSEROTH AB
Citation: W. Zhang et Ab. Deisseroth, CONFORMATIONAL CHANGE OF P53 PROTEIN IN GROWTH FACTOR-STIMULATED HUMAN MYELOGENOUS LEUKEMIA-CELLS, Leukemia & lymphoma, 14(3-4), 1994, pp. 251-255
THE REQUIREMENT OF THE CARBOXYL-TERMINUS OF P53 FOR DNA-BINDING AND TRANSCRIPTIONAL ACTIVATION DEPENDS ON THE SPECIFIC P53 BINDING DNA ELEMENT
Authors: ZHANG W GUO XYD DEISSEROTH AB
Citation: W. Zhang et al., THE REQUIREMENT OF THE CARBOXYL-TERMINUS OF P53 FOR DNA-BINDING AND TRANSCRIPTIONAL ACTIVATION DEPENDS ON THE SPECIFIC P53 BINDING DNA ELEMENT, Oncogene, 9(9), 1994, pp. 2513-2521
SERIAL TRANSPLANTATION SHOWS THAT EARLY HEMATOPOIETIC PRECURSOR CELLSARE TRANSDUCED BY MDR-1 RETROVIRAL VECTOR IN A MOUSE GENE-THERAPY MODEL
Authors: HANANIA EG DEISSEROTH AB
Citation: Eg. Hanania et Ab. Deisseroth, SERIAL TRANSPLANTATION SHOWS THAT EARLY HEMATOPOIETIC PRECURSOR CELLSARE TRANSDUCED BY MDR-1 RETROVIRAL VECTOR IN A MOUSE GENE-THERAPY MODEL, Cancer gene therapy, 1(1), 1994, pp. 21-25
INTERACTION OF NUCLEAR PROTEINS WITH AN AP-1 CRE-LIKE PROMOTER SEQUENCE IN THE HUMAN TNF-ALPHA GENE
Authors: NEWELL CL DEISSEROTH AB LOPEZBERESTEIN G
Citation: Cl. Newell et al., INTERACTION OF NUCLEAR PROTEINS WITH AN AP-1 CRE-LIKE PROMOTER SEQUENCE IN THE HUMAN TNF-ALPHA GENE, Journal of leukocyte biology, 56(1), 1994, pp. 27-35
ETOPOSIDE, CYCLOPHOSPHAMIDE, TOTAL-BODY IRRADIATION, AND ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES
Authors: GIRALT SA LEMAISTRE CF VRIESENDORP HM ANDERSSON BS DIMOPOULOS M GAJEWSKI J VANBESIEN K MEHRA R PRZEPIORKA D KHOURI I YAU J KANTARJIAN H DEISSEROTH AB CHAMPLIN RE
Citation: Sa. Giralt et al., ETOPOSIDE, CYCLOPHOSPHAMIDE, TOTAL-BODY IRRADIATION, AND ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES, Journal of clinical oncology, 12(9), 1994, pp. 1923-1930
AUTOLOGOUS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC-LEUKEMIA - PRELIMINARY-RESULTS
Authors: KHOURI IF KEATING MJ VRIESENDORP HM READING CL PRZEPIORKA D HUH YO ANDERSSON BS VANBESIEN KW MEHRA RC GIRALT SA IPPOLITI C MARSHALL M THOMAS MW OBRIEN S ROBERTSON LE DEISSEROTH AB CHAMPLIN RE
Citation: If. Khouri et al., AUTOLOGOUS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC-LEUKEMIA - PRELIMINARY-RESULTS, Journal of clinical oncology, 12(4), 1994, pp. 748-758
MARKING WITH SAFETY-MODIFIED RETROVIRUSES GENERATES GENETICALLY-MARKED NORMAL-CELLS WHICH CIRCULATE FOR UP TO 6 MONTHS AFTER CHRONIC MYELOGENOUS LEUKEMIA AUTOLOGOUS TRANSPLANTS AND SHOWS THAT RELAPSE ARISES FROM THE INFUSED MARROW
Authors: DEISSEROTH AB ZU Z CLAXTON D HANANIA EG FU S TALPAZ M KANTARJIAN H CHAMPLIN R
Citation: Ab. Deisseroth et al., MARKING WITH SAFETY-MODIFIED RETROVIRUSES GENERATES GENETICALLY-MARKED NORMAL-CELLS WHICH CIRCULATE FOR UP TO 6 MONTHS AFTER CHRONIC MYELOGENOUS LEUKEMIA AUTOLOGOUS TRANSPLANTS AND SHOWS THAT RELAPSE ARISES FROM THE INFUSED MARROW, Experimental hematology, 22(8), 1994, pp. 681-681
CONFERRING CHEMORESISTANCE PHENOTYPE UPON HEMATOPOIETIC PROGENITOR CELLS USING THE MULTIPLE-DRUG RESISTANCE GENE IN A SAFETY-MODIFIED RETROVIRAL VECTOR
Authors: HANANIA EG FU SO HILL L WANG T DEISSEROTH AB
Citation: Eg. Hanania et al., CONFERRING CHEMORESISTANCE PHENOTYPE UPON HEMATOPOIETIC PROGENITOR CELLS USING THE MULTIPLE-DRUG RESISTANCE GENE IN A SAFETY-MODIFIED RETROVIRAL VECTOR, Experimental hematology, 22(8), 1994, pp. 699-699
IDENTIFICATION OF HYPERGLYCOSYLATED E-SELECTING (ELAM-1) EXPRESSION ON NORMAL AND LEUKEMIC HEMATOPOIETIC-CELLS
Authors: KOBERDA J PRZEPIORKA D BEDNARCZYK J ESCUDIER S CHAMPLIN RE DEISSEROTH AB MCINTYRE BW
Citation: J. Koberda et al., IDENTIFICATION OF HYPERGLYCOSYLATED E-SELECTING (ELAM-1) EXPRESSION ON NORMAL AND LEUKEMIC HEMATOPOIETIC-CELLS, Experimental hematology, 22(8), 1994, pp. 711-711
THE EFFECTS OF MISSENSE MUTATIONS, DELETION, AND PHOSPHORYLATION ON THE TRANSCRIPTION AND ANTIPROLIFERATIVE FUNCTIONS OF HUMAN TUMOR-SUPPRESSOR P53
Authors: ZHANG W GUO XY MCCLAIN C DEISSEROTH AB PRZEPIORKA D
Citation: W. Zhang et al., THE EFFECTS OF MISSENSE MUTATIONS, DELETION, AND PHOSPHORYLATION ON THE TRANSCRIPTION AND ANTIPROLIFERATIVE FUNCTIONS OF HUMAN TUMOR-SUPPRESSOR P53, Experimental hematology, 22(8), 1994, pp. 721-721
NOVEL SITES IN THE PROMOTER OF THE INTERFERON REGULATORY FACTOR-2 WERE FOUND TO REGULATE ITS EXPRESSION
Authors: CHA Y DEISSEROTH AB CHAMPLIN R
Citation: Y. Cha et al., NOVEL SITES IN THE PROMOTER OF THE INTERFERON REGULATORY FACTOR-2 WERE FOUND TO REGULATE ITS EXPRESSION, Experimental hematology, 22(8), 1994, pp. 748-748
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>